Turhan TOGAN, Recep DURSUN, Hale Turan ÖZDEN

Mycobacterium Fortuitum'a Bağlı Deri İnfeksiyonu

Non tüberküloz mikobakterilerin yol açtığı kutanöz infeksiyonlar nadirdir ve tanı koymak oldukça güçtür. Hızlı üreyen mikobakteriler immunkompromize hastalarda deri ve yumuşak doku infeksiyonuna neden olabilirler. Mycobacterium fortuitum hızlı üreyen mikobakterilerdendir. Bu makalede immunkompetan bir hastada M. fortuitum'un etken olarak izole edildiği bir deri infeksiyon olgusu sunulmuştur. Hastamız 12 hafta peroral yolla verilen klaritromisin ve siprofloksasin tedavisiyle tam olarak iyileşmiştir.

A Cutaneous Infection Due to Mycobacterium Fortuitum

Cutaneous infections caused by non-tuberculous mycobacteria are uncommon and are so difficult to diagnose. Rapidly growing mycobacteria can cause skin and soft tissue infections in immunocompromised patients. Mycobacterium fortuitum is one of the rapidly growing mycobacterium. In this article, in an immuncompetent patient, we present a case of cutaneous infection in which M. fortuitum is isolated. Our patient recovered completely by clarithromycin and ciprofloxacin treatment given perorally for 12 weeks.

PDF

___

1.Griffith DE. ATS Mycobacterial Diseases Subcommitee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med.2007;175:367-416.
2.Wallace RJ, Jr., SJ, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis.1983;5:657-79.
3.Wentworth AB, Drage LA, Wengenack NL Wilson JW, Lohse CM. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: A population-based study. Mayo Clin Proc.2013;88:38-45.
4.Brown-Elliot BA. Wallace RJ. Infections due to nontuberculous Mycobacteria other than Mycobacterium avium-intarcellulare. in Mandell GL, Bennett JE, Dolin R, Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 7th edition. Philadelphia: Churchill Livingstone.2010;3191-8.
5.Toth EL, Boychuk LR, Kirkland PA. Recurrent infection of continous subcutaneous insulin sites with Mycobacterium fortuitum. Diabetes Care.1995;18:1284-5.
6.Sethi S, Arora S, Gupta V, Kumar S. Cutaneous Mycobacterium fortuitum infection. Succesfully treated with amikacin and ofloxacin combination. Indian J Dermatol.2014;59:383-4.
7. Wallace RJ, Jr Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis.1985;152:500-14.
8.Quiñones C, Ramalle-Gómara E, Perucha M, Lezaun ME, Fernandez-Vilariño, Garcia-Morrás P, Simal G. An outbreak of Mycobacterium fortuitum cutaneous infection associated with mesotherapy. J Eur Acad Dermatol Venereol. 2010;24:604-6.
9.Silvestre Salvador JF, Betloch MI, Alfonso R, Ramón RL, Morell AM, Navas J. Disseminated skin infection due to Mycobacterium fortuitum in an immunocompetent patient. J Eur Acad Dermatol Venereol.1998;11:158-61.